Brace Pharma

Summary

Brace Pharma is the famous VC, which was founded in 2013. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Rockville.

Speaking about the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2018. Opposing the other organizations, this Brace Pharma works on 2 percentage points more the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.

We also calculated 2 valuable employees in our database.

Among the most popular portfolio startups of the fund, we may highlight F2G, Antiva Biosciences, Navitor Pharmaceuticals. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Genetics, Health Diagnostics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Brace Pharma, startups are often financed by Atlas Venture, Amgen Ventures, Remeditex Ventures. The meaningful sponsors for the fund in investment in the same round are Atlas Venture, Sectoral Asset Management, Remeditex Ventures. In the next rounds fund is usually obtained by Perceptive Advisors, Logos Capital, Square 1 Bank.